Search research articles
Contact Us
Filters
Showing results (151-160 of 158) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 158 results.
Nature Communications
|
May 6, 2020
Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection
Emily Adland, Jane Millar, Nomonde Bengu, et al.
Frontiers in Medicine
|
July 22, 2024
Long COVID: cognitive, balance, and retina manifestations
Meritxell Carmona-Cervelló, Brenda Biaani León-Gómez, Rosalia Dacosta-Aguayo, et al.
Iscience
|
November 2, 2022
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
Erola Ainsua-Enrich, Núria Pedreño-Lopez, Carmen Bracke, et al.
The Journal of Infectious Diseases
|
October 6, 2022
Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution
Susana Benet, Oscar Blanch-Lombarte, Erola Ainsua-Enrich, et al.
Journal of Virology
|
November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection
Emily Adland, Matilda Hill, Nora Lavandier, et al.
Nature
|
February 27, 2009
Adaptation of HIV-1 to human leukocyte antigen class I
Yuka Kawashima, Katja Pfafferott, John Frater, et al.
Vaccine
|
January 14, 2025
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
The Lancet Regional Health. Europe
|
May 3, 2023
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 158) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 158 results.
Nature Communications
|
May 6, 2020
Author Correction: Sex-specific innate immune selection of HIV-1 in utero is associated with increased female susceptibility to infection
Emily Adland, Jane Millar, Nomonde Bengu, et al.
Frontiers in Medicine
|
July 22, 2024
Long COVID: cognitive, balance, and retina manifestations
Meritxell Carmona-Cervelló, Brenda Biaani León-Gómez, Rosalia Dacosta-Aguayo, et al.
Iscience
|
November 2, 2022
Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
Erola Ainsua-Enrich, Núria Pedreño-Lopez, Carmen Bracke, et al.
The Journal of Infectious Diseases
|
October 6, 2022
Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution
Susana Benet, Oscar Blanch-Lombarte, Erola Ainsua-Enrich, et al.
Journal of Virology
|
November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection
Emily Adland, Matilda Hill, Nora Lavandier, et al.
Nature
|
February 27, 2009
Adaptation of HIV-1 to human leukocyte antigen class I
Yuka Kawashima, Katja Pfafferott, John Frater, et al.
Vaccine
|
January 14, 2025
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
The Lancet Regional Health. Europe
|
May 3, 2023
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
Júlia Corominas, Carme Garriga, Antoni Prenafeta, et al.
Page
of 16